TRAF1 is a critical regulator of cerebral ischaemia–reperfusion injury and neuronal death

Stroke is a leading global cause of mortality and disability. Less than 5% of patients are able to receive tissue plasminogen activator thrombolysis within the necessary timeframe. Focusing on the process of neuronal apoptosis in the penumbra, which lasts from hours to days after ischaemia, appears to be promising. Here we report that tumour necrosis factor receptor-associated factor 1 (TRAF1) expression is markedly induced in wild-type mice 6 h after stroke onset. Using genetic approaches, we demonstrate that increased neuronal TRAF1 leads to elevated neuronal death and enlarged ischaemic lesions, whereas TRAF1 deficiency is neuroprotective. In addition, TRAF1-mediated neuroapoptosis correlates with the activation of the JNK pro-death pathway and inhibition of the Akt cell survival pathway. Finally, TRAF1 is found to exert pro-apoptotic effects via direct interaction with ASK1. Thus, ASK1 positively and negatively regulates the JNK and Akt signalling pathways, respectively. Targeting the TRAF1/ASK1 pathway may provide feasible therapies for stroke long after onset.

[1]  H. Ichijo,et al.  Apoptosis signal-regulating kinase 1 in stress and immune response. , 2008, Annual review of pharmacology and toxicology.

[2]  Peter Scheurich,et al.  The Human Tumor Necrosis Factor (TNF) Receptor-associated Factor 1 Gene (TRAF1) Is Up-regulated by Cytokines of the TNF Ligand Family and Modulates TNF-induced Activation of NF-κB and c-Jun N-terminal Kinase* , 1999, The Journal of Biological Chemistry.

[3]  A. Vercelli,et al.  Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation , 2007, Neuroscience.

[4]  J. Baik,et al.  Caspase-cleaved TRAF1 negatively regulates the antiapoptotic signals of TRAF2 during TNF-induced cell death. , 2001, Biochemical and biophysical research communications.

[5]  J. Tschopp,et al.  Caspase‐induced inactivation of the anti‐apoptotic TRAF1 during Fas ligand‐mediated apoptosis , 2000, FEBS letters.

[6]  David W. Johnson,et al.  Patient samples of renal cell carcinoma show reduced expression of TRAF1 compared with normal kidney and functional studies in vitro indicate TRAF1 promotes apoptosis: potential for targeted therapy , 2012, Pathology.

[7]  L. Chao,et al.  Postischemic Brain Injury Is Exacerbated in Mice Lacking the Kinin B2 Receptor , 2006, Hypertension.

[8]  D. Goeddel,et al.  Anatomy of TRAF2 , 1996, The Journal of Biological Chemistry.

[9]  D. Green,et al.  Withdrawal of Survival Factors Results in Activation of the JNK Pathway in Neuronal Cells Leading to Fas Ligand Induction and Cell Death , 1999, Molecular and Cellular Biology.

[10]  H. Nakano,et al.  Tumor necrosis factor receptor‐associated factor 5 is an essential mediator of ischemic brain infarction , 2013, Journal of neurochemistry.

[11]  Soo Young Lee,et al.  TRAF1 and its biological functions. , 2007, Advances in experimental medicine and biology.

[12]  Li Yang,et al.  SHPS‐1 deficiency induces robust neuroprotection against experimental stroke by attenuating oxidative stress , 2012, Journal of neurochemistry.

[13]  M. Moskowitz,et al.  Pathobiology of ischaemic stroke: an integrated view , 1999, Trends in Neurosciences.

[14]  Alexei Degterev,et al.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury , 2005, Nature chemical biology.

[15]  Hongliang Li,et al.  Mindin is a critical mediator of ischemic brain injury in an experimental stroke model , 2013, Experimental Neurology.

[16]  Liang Cheng,et al.  Potential for targeted therapy in prostate cancers with ERG abnormalities. , 2011, Asian journal of andrology.

[17]  N. Takahashi,et al.  Inhibition of Protein Kinase Akt1 by Apoptosis Signal-regulating Kinase-1 (ASK1) Is Involved in Apoptotic Inhibition of Regulatory Volume Increase* , 2010, The Journal of Biological Chemistry.

[18]  D. Reutens,et al.  Apoptotic mechanisms after cerebral ischemia. , 2009, Stroke.

[19]  C. Ware,et al.  The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family , 1995, Cell.

[20]  Jun Chen,et al.  Peroxiredoxin-2 Protects against 6-Hydroxydopamine-Induced Dopaminergic Neurodegeneration via Attenuation of the Apoptosis Signal-Regulating Kinase (ASK1) Signaling Cascade , 2011, The Journal of Neuroscience.

[21]  Young Chul Park,et al.  All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. , 2002, Journal of cell science.

[22]  D. Goeddel,et al.  A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor , 1994, Cell.

[23]  John Calvin Reed,et al.  TRAF1 Is a Substrate of Caspases Activated during Tumor Necrosis Factor Receptor-α-induced Apoptosis* , 2001, The Journal of Biological Chemistry.

[24]  Xingshun Xu,et al.  Synergistic protective effects of humanin and necrostatin-1 on hypoxia and ischemia/reperfusion injury , 2010, Brain Research.

[25]  Emma E Vincent,et al.  Akt signalling in health and disease. , 2011, Cellular signalling.

[26]  H. Ichijo,et al.  ASK1 promotes apoptosis of normal and malignant plasma cells. , 2012, Blood.

[27]  L. Wang,et al.  Increased inflammation and brain injury after transient focal cerebral ischemia in activating transcription factor 3 knockout mice , 2012, Neuroscience.

[28]  M. Tymianski.  Emerging mechanisms of disrupted cellular signaling in brain ischemia , 2011, Nature Neuroscience.

[29]  Masanori Aikawa,et al.  TRAF-1, -2, -3, -5, and -6 Are Induced in Atherosclerotic Plaques and Differentially Mediate Proinflammatory Functions of CD40L in Endothelial Cells , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[30]  P. Scheurich,et al.  Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation. , 2004, The Journal of biological chemistry.

[31]  Yanqin Gao,et al.  Neuroprotection against Focal Ischemic Brain Injury by Inhibition of c-Jun N-Terminal Kinase and Attenuation of the Mitochondrial Apoptosis-Signaling Pathway , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  C. Bonny,et al.  JNK inhibition and inflammation after cerebral ischemia , 2010, Brain, Behavior, and Immunity.

[33]  A. Vercelli,et al.  A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia , 2003, Nature Medicine.

[34]  C. Y. Wang,et al.  NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.

[35]  R. Sapolsky,et al.  Phosphoinositide-3-kinase/Akt survival signal pathways are implicated in neuronal survival after stroke , 2006, Molecular Neurobiology.

[36]  P. Scheurich,et al.  Tumor Necrosis Factor Receptor-associated Factor (TRAF) 1 Regulates CD40-induced TRAF2-mediated NF-κB Activation* , 2004, Journal of Biological Chemistry.

[37]  Ruth E. Hartley,et al.  An integrated view. , 1973 .

[38]  M. Ginsberg.  Current status of neuroprotection for cerebral ischemia: synoptic overview. , 2009, Stroke.

[39]  F. Urano,et al.  Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. , 2005, Cell death and differentiation.

[40]  The endogenous inhibitor of Akt, CTMP, is critical to ischemia-induced neuronal death , 2009, Nature Neuroscience.

[41]  K. Miyazono,et al.  ASK1 is essential for JNK/SAPK activation by TRAF2. , 1998, Molecular cell.

[42]  Eng H. Lo,et al.  Neurological diseases: Mechanisms, challenges and opportunities in stroke , 2003, Nature Reviews Neuroscience.

[43]  Feng Zhang,et al.  Hsp27 Protects against Ischemic Brain Injury via Attenuation of a Novel Stress-Response Cascade Upstream of Mitochondrial Cell Death Signaling , 2008, The Journal of Neuroscience.

[44]  P. Rakic,et al.  A critical role of neural-specific JNK3 for ischemic apoptosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Minoru Takagi,et al.  Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.

[46]  H. Ichijo,et al.  Impact of Mitochondrial Reactive Oxygen Species and Apoptosis Signal–Regulating Kinase 1 on Insulin Signaling , 2006, Diabetes.

[47]  Yongwon Choi,et al.  Regulation of the Subcellular Localization of Tumor Necrosis Factor Receptor–associated Factor (TRAF)2 by TRAF1 Reveals Mechanisms of TRAF2 Signaling , 2002, The Journal of experimental medicine.

[48]  R. Gascoyne,et al.  TNFR-Associated Factor Family Protein Expression in Normal Tissues and Lymphoid Malignancies , 2000, The Journal of Immunology.

[49]  Jun Chen,et al.  Potential Molecular Targets for Translational Stroke Research , 2009, Stroke.